Literature DB >> 16908056

National Cholesterol Education Program risk assessment and potential for risk misclassification.

Stephen D Persell1, Donald M Lloyd-Jones, David W Baker.   

Abstract

BACKGROUND: The National Cholesterol Education Program Adult Treatment Panel report from 2001 (ATP III) recommends clinicians calculate 10-year coronary risk using multivariable methods only for adults with 2 or more risk factors. We aimed to determine who would be falsely classified as low risk using this approach.
METHODS: We studied 4097 adults aged 20 to 79 years without diagnosed cardiovascular disease or diabetes from the National Health and Nutrition Examination Survey from 1999 to 2002. We determined the proportion with fewer than 2 risk factors who nonetheless had estimated 10-year risk of cardiac death or myocardial infarction > or =10% using multivariable methods.
RESULTS: Among persons with fewer than 2 risk factors, 5.3% (95% confidence interval 4.7 to 6.1%), had a 10-year risk > or =10% using the Framingham Risk Score and would be misclassified using the risk factor counting method (this corresponds to approximately 5,640,000 U.S. adults). Compared to individuals whose classification was unchanged, those misclassified as low risk were older (P<0.001) and more likely male (85.5% vs. 41.2%, P<0.001).
CONCLUSIONS: Relying on the ATP III risk factor counting method rather than determining risk using multivariable methods in all patients resulted in misclassifiying as low risk over 5 million adults with at least moderately high risk of coronary heart disease, most of whom are middle-aged and older men.

Entities:  

Mesh:

Year:  2006        PMID: 16908056     DOI: 10.1016/j.ypmed.2006.06.017

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  9 in total

Review 1.  Cardiovascular risk assessment: a global perspective.

Authors:  Dong Zhao; Jing Liu; Wuxiang Xie; Yue Qi
Journal:  Nat Rev Cardiol       Date:  2015-03-10       Impact factor: 32.419

2.  Novel cardiovascular risk prediction models in patients with systemic lupus erythematosus.

Authors:  V K Kawai; J F Solus; A Oeser; Y H Rho; P Raggi; A Bian; T Gebretsadik; A Shintani; C M Stein
Journal:  Lupus       Date:  2011-10-05       Impact factor: 2.911

3.  Acceptance of a Polypill approach to prevent cardiovascular disease among a sample of U.S. physicians.

Authors:  Anthony J Viera; Stacey L Sheridan; Teresa Edwards; Elsayed Z Soliman; Russell Harris; Curt D Furberg
Journal:  Prev Med       Date:  2010-10-08       Impact factor: 4.018

4.  Assessing coronary risk assessment: what's next?

Authors:  Kevin Fiscella; Peter Franks
Journal:  J Gen Intern Med       Date:  2010-11       Impact factor: 5.128

5.  Coronary risk assessment by point-based vs. equation-based Framingham models: significant implications for clinical care.

Authors:  William J Gordon; Jesse M Polansky; W John Boscardin; Kathy Z Fung; Michael A Steinman
Journal:  J Gen Intern Med       Date:  2010-09-08       Impact factor: 5.128

6.  Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool.

Authors:  Margaret W Cavanaugh-Hussey; Jarett D Berry; Donald M Lloyd-Jones
Journal:  Prev Med       Date:  2008-07-29       Impact factor: 4.018

Review 7.  Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.

Authors:  Allison B Reiss; Benna Jacob; Saba Ahmed; Steven E Carsons; Joshua DeLeon
Journal:  Inflammation       Date:  2021-04-05       Impact factor: 4.092

8.  A double-blind, placebo-controlled pilot study to evaluate the effect of calcium fructoborate on systemic inflammation and dyslipidemia markers for middle-aged people with primary osteoarthritis.

Authors:  Romulus Scorei; Paul Mitrut; Iulian Petrisor; Iulia Scorei
Journal:  Biol Trace Elem Res       Date:  2011-05-24       Impact factor: 3.738

9.  Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure.

Authors:  Aakash Bavishi; Donald M Lloyd-Jones; Hongyan Ning; Thanh Huyen T Vu; Clyde W Yancy; Sanjiv J Shah; Mercedes Carnethon; Sadiya S Khan
Journal:  PLoS One       Date:  2020-11-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.